OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
Annemiek Vermeeren, Stefan Jongen, Patricia Murphy, et al.
SLEEP (2018) Vol. 42, Iss. 4
Open Access | Times Cited: 215
Annemiek Vermeeren, Stefan Jongen, Patricia Murphy, et al.
SLEEP (2018) Vol. 42, Iss. 4
Open Access | Times Cited: 215
Showing 26-50 of 215 citing articles:
Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer’s Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant
Carsten T. Beuckmann, Hiroyuki Suzuki, Erik S. Musiek, et al.
Journal of Alzheimer s Disease (2021) Vol. 81, Iss. 3, pp. 1151-1167
Open Access | Times Cited: 17
Carsten T. Beuckmann, Hiroyuki Suzuki, Erik S. Musiek, et al.
Journal of Alzheimer s Disease (2021) Vol. 81, Iss. 3, pp. 1151-1167
Open Access | Times Cited: 17
Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers
Kunihiro Iwamoto, Mari Iwata, Daiji Kambe, et al.
Psychopharmacology (2022) Vol. 239, Iss. 3, pp. 841-850
Closed Access | Times Cited: 8
Kunihiro Iwamoto, Mari Iwata, Daiji Kambe, et al.
Psychopharmacology (2022) Vol. 239, Iss. 3, pp. 841-850
Closed Access | Times Cited: 8
Review of the Efficacy and Safety of Lemborexant, a Dual Receptor Orexin Antagonist (DORA), in the Treatment of Adults With Insomnia Disorder
Kristin Waters
Annals of Pharmacotherapy (2021) Vol. 56, Iss. 2, pp. 213-221
Closed Access | Times Cited: 11
Kristin Waters
Annals of Pharmacotherapy (2021) Vol. 56, Iss. 2, pp. 213-221
Closed Access | Times Cited: 11
Efficacy and safety of lemborexant in midlife women with insomnia disorder
Masakazu Terauchi, Jocelyn Y. Cheng, Jane Yardley, et al.
Menopause The Journal of The North American Menopause Society (2023) Vol. 30, Iss. 8, pp. 839-848
Open Access | Times Cited: 4
Masakazu Terauchi, Jocelyn Y. Cheng, Jane Yardley, et al.
Menopause The Journal of The North American Menopause Society (2023) Vol. 30, Iss. 8, pp. 839-848
Open Access | Times Cited: 4
Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers
Hans‐Jürgen Möller, Hans‐Peter Volz, Erich Seifritz, et al.
Journal of Psychiatric Research (2020) Vol. 136, pp. 543-551
Open Access | Times Cited: 10
Hans‐Jürgen Möller, Hans‐Peter Volz, Erich Seifritz, et al.
Journal of Psychiatric Research (2020) Vol. 136, pp. 543-551
Open Access | Times Cited: 10
Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors
Takashi Ueno, Yukiko Miyajima, Ishani Landry, et al.
CPT Pharmacometrics & Systems Pharmacology (2021) Vol. 10, Iss. 5, pp. 455-466
Open Access | Times Cited: 10
Takashi Ueno, Yukiko Miyajima, Ishani Landry, et al.
CPT Pharmacometrics & Systems Pharmacology (2021) Vol. 10, Iss. 5, pp. 455-466
Open Access | Times Cited: 10
Effectiveness of change from suvorexant to lemborexant drug in the treatment of sleep disorders
Kazumaro Okino, Hirohisa Suzuki, Seiji Kondo, et al.
Psychogeriatrics (2022) Vol. 22, Iss. 5, pp. 595-604
Closed Access | Times Cited: 7
Kazumaro Okino, Hirohisa Suzuki, Seiji Kondo, et al.
Psychogeriatrics (2022) Vol. 22, Iss. 5, pp. 595-604
Closed Access | Times Cited: 7
Molecular basis for anti-insomnia drug design from structure of lemborexant-bound orexin 2 receptor
Hidetsugu Asada, Dohyun Im, Yunhon Hotta, et al.
Structure (2022) Vol. 30, Iss. 12, pp. 1582-1589.e4
Open Access | Times Cited: 7
Hidetsugu Asada, Dohyun Im, Yunhon Hotta, et al.
Structure (2022) Vol. 30, Iss. 12, pp. 1582-1589.e4
Open Access | Times Cited: 7
Evaluating lemborexant for the treatment of insomnia
Gary Zammit, Andrew D. Krystal
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 10, pp. 1235-1243
Closed Access | Times Cited: 7
Gary Zammit, Andrew D. Krystal
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 10, pp. 1235-1243
Closed Access | Times Cited: 7
Pharmacologic Approach to Insomnia
Lina Fine
Physical Medicine and Rehabilitation Clinics of North America (2020) Vol. 31, Iss. 2, pp. 255-264
Closed Access | Times Cited: 7
Lina Fine
Physical Medicine and Rehabilitation Clinics of North America (2020) Vol. 31, Iss. 2, pp. 255-264
Closed Access | Times Cited: 7
Sleep modulating agents
Younggi Choi, Brian Raymer
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 16, pp. 2025-2033
Closed Access | Times Cited: 6
Younggi Choi, Brian Raymer
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 16, pp. 2025-2033
Closed Access | Times Cited: 6
Comparison of the effect of lemborexant and other insomnia treatments on driving performance: a systematic review and meta-analysis
Heather McElroy, Beth O’Leary, Michael Adena, et al.
SLEEP Advances (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 6
Heather McElroy, Beth O’Leary, Michael Adena, et al.
SLEEP Advances (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 6
The effects of different dosages of dual orexin receptor antagonists and zolpidem on sleep and cognitive function: A meta-analysis and systematic review
Mengzhen Zhou, Rujia Liu, Zhengqi Xie
Sleep Epidemiology (2023) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 2
Mengzhen Zhou, Rujia Liu, Zhengqi Xie
Sleep Epidemiology (2023) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 2
Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users
Ishani Landry, Nancy Hall, Jagadeesh Alur, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 4, pp. 374-382
Open Access | Times Cited: 4
Ishani Landry, Nancy Hall, Jagadeesh Alur, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 4, pp. 374-382
Open Access | Times Cited: 4
Interpol review of toxicology 2019–2022
Jack Yuk-ki Cheng, Janesse Wing-Sze Hui, Wing-sum Chan, et al.
Forensic Science International Synergy (2022) Vol. 6, pp. 100303-100303
Open Access | Times Cited: 4
Jack Yuk-ki Cheng, Janesse Wing-Sze Hui, Wing-sum Chan, et al.
Forensic Science International Synergy (2022) Vol. 6, pp. 100303-100303
Open Access | Times Cited: 4
Development and validation of a driving simulator for evaluating the residual effects of drugs on driving performance – sensitivity analysis using zopiclone as a positive control
Mari Iwata, Kunihiro Iwamoto, Daiji Kambe, et al.
Medicine (2020) Vol. 99, Iss. 12, pp. e19395-e19395
Open Access | Times Cited: 5
Mari Iwata, Kunihiro Iwamoto, Daiji Kambe, et al.
Medicine (2020) Vol. 99, Iss. 12, pp. e19395-e19395
Open Access | Times Cited: 5
How to read a paper on the short-term impairing effects of cannabis: A selective and critical review of the literature
Michael A. White, Nicholas R. Burns
Drug Science Policy and Law (2022) Vol. 8
Open Access | Times Cited: 3
Michael A. White, Nicholas R. Burns
Drug Science Policy and Law (2022) Vol. 8
Open Access | Times Cited: 3
Effects of zuranolone on next-day simulated driving in healthy adults
Joi Dunbar, Gaetano Morelli, Rakesh K. Jain, et al.
Psychopharmacology (2024)
Open Access
Joi Dunbar, Gaetano Morelli, Rakesh K. Jain, et al.
Psychopharmacology (2024)
Open Access
A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists
Andrea Murphy, Korolos Sawires, Sophie Peltekian, et al.
Exploratory Research in Clinical and Social Pharmacy (2024) Vol. 16, pp. 100538-100538
Open Access
Andrea Murphy, Korolos Sawires, Sophie Peltekian, et al.
Exploratory Research in Clinical and Social Pharmacy (2024) Vol. 16, pp. 100538-100538
Open Access
Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan
Rintaro Sogawa, Masakazu Hatano, Fusanori Nishimura, et al.
In Vivo (2024) Vol. 39, Iss. 1, pp. 433-439
Open Access
Rintaro Sogawa, Masakazu Hatano, Fusanori Nishimura, et al.
In Vivo (2024) Vol. 39, Iss. 1, pp. 433-439
Open Access
Effect of different doses of almorexant on learning and memory in 8-month-old APP/PS1 (AD) mice
Mengzhen Zhou, Yanran Li
Peptides (2023) Vol. 167, pp. 171044-171044
Closed Access | Times Cited: 1
Mengzhen Zhou, Yanran Li
Peptides (2023) Vol. 167, pp. 171044-171044
Closed Access | Times Cited: 1
Effects of new hypnotic drugs on cognition: A systematic review and network meta-analysis
Mengzhen Zhou, Rujia Liu, Jiyou Tang, et al.
Sleep Medicine X (2023) Vol. 6, pp. 100094-100094
Open Access | Times Cited: 1
Mengzhen Zhou, Rujia Liu, Jiyou Tang, et al.
Sleep Medicine X (2023) Vol. 6, pp. 100094-100094
Open Access | Times Cited: 1
C-L Case Conference: Insomnia Disorder
Vanessa Aversa, Raed Hawa, Elliott Kyung Lee, et al.
Journal of the Academy of Consultation-Liaison Psychiatry (2023) Vol. 65, Iss. 3, pp. 293-301
Closed Access | Times Cited: 1
Vanessa Aversa, Raed Hawa, Elliott Kyung Lee, et al.
Journal of the Academy of Consultation-Liaison Psychiatry (2023) Vol. 65, Iss. 3, pp. 293-301
Closed Access | Times Cited: 1
